280 related articles for article (PubMed ID: 24316979)
1. Inactivating CUX1 mutations promote tumorigenesis.
Wong CC; Martincorena I; Rust AG; Rashid M; Alifrangis C; Alexandrov LB; Tiffen JC; Kober C; ; Green AR; Massie CE; Nangalia J; Lempidaki S; Döhner H; Döhner K; Bray SJ; McDermott U; Papaemmanuil E; Campbell PJ; Adams DJ
Nat Genet; 2014 Jan; 46(1):33-8. PubMed ID: 24316979
[TBL] [Abstract][Full Text] [Related]
2. CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.
Ramdzan ZM; Nepveu A
Nat Rev Cancer; 2014 Oct; 14(10):673-82. PubMed ID: 25190083
[TBL] [Abstract][Full Text] [Related]
3. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.
An N; Khan S; Imgruet MK; Gurbuxani SK; Konecki SN; Burgess MR; McNerney ME
Blood; 2018 Jun; 131(24):2682-2697. PubMed ID: 29592892
[TBL] [Abstract][Full Text] [Related]
4. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.
McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP
Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.
Siam R; Harada R; Cadieux C; Battat R; Vadnais C; Nepveu A
Mol Cancer; 2009 Aug; 8():60. PubMed ID: 19656388
[TBL] [Abstract][Full Text] [Related]
6. Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.
Supper E; Rudat S; Iyer V; Droop A; Wong K; Spinella JF; Thomas P; Sauvageau G; Adams DJ; Wong CC
Nat Commun; 2021 Apr; 12(1):2482. PubMed ID: 33931647
[TBL] [Abstract][Full Text] [Related]
7. RAS transformation requires CUX1-dependent repair of oxidative DNA damage.
Ramdzan ZM; Vadnais C; Pal R; Vandal G; Cadieux C; Leduy L; Davoudi S; Hulea L; Yao L; Karnezis AN; Paquet M; Dankort D; Nepveu A
PLoS Biol; 2014 Mar; 12(3):e1001807. PubMed ID: 24618719
[TBL] [Abstract][Full Text] [Related]
8. The multiple roles of CUX1: insights from mouse models and cell-based assays.
Sansregret L; Nepveu A
Gene; 2008 Apr; 412(1-2):84-94. PubMed ID: 18313863
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of CUX1 influences autophagy activation in paroxysmal nocturnal hemoglobinuria.
Wu J; Li L; Liu Z; Wang H; Chen Y; Zeng L; Wang G; Liu H; Fu R
J Leukoc Biol; 2024 Apr; 115(5):926-934. PubMed ID: 38315716
[TBL] [Abstract][Full Text] [Related]
10. p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin.
Kedinger V; Sansregret L; Harada R; Vadnais C; Cadieux C; Fathers K; Park M; Nepveu A
J Biol Chem; 2009 Oct; 284(40):27701-11. PubMed ID: 19635798
[TBL] [Abstract][Full Text] [Related]
11. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
[TBL] [Abstract][Full Text] [Related]
13. CUX1 transcription factor is a downstream effector of the proteinase-activated receptor 2 (PAR2).
Wilson BJ; Harada R; LeDuy L; Hollenberg MD; Nepveu A
J Biol Chem; 2009 Jan; 284(1):36-45. PubMed ID: 18952606
[TBL] [Abstract][Full Text] [Related]
14. CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling.
Kühnemuth B; Mühlberg L; Schipper M; Griesmann H; Neesse A; Milosevic N; Wissniowski T; Buchholz M; Gress TM; Michl P
Oncogene; 2015 Jan; 34(2):177-87. PubMed ID: 24336331
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral heterogeneity for inactivating frameshift mutation of CUX1 and SIRT1 genes in gastric and colorectal cancers.
Jo YS; Kim MS; Yoo NJ; Lee SH
Pol J Pathol; 2017; 68(3):258-260. PubMed ID: 29363918
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.
Topka S; Glassmann A; Weisheit G; Schüller U; Schilling K
Cerebellum; 2014 Dec; 13(6):698-712. PubMed ID: 25096634
[TBL] [Abstract][Full Text] [Related]
17. CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer.
Zhang M; Wang Q; Ding Y; Wang G; Chu Y; He X; Wu X; Shao YW; Lu K
J Thorac Oncol; 2018 Nov; 13(11):1792-1797. PubMed ID: 30010043
[TBL] [Abstract][Full Text] [Related]
18. Asynchronous expression of the homeodomain protein CUX1 in Sertoli cells and spermatids during spermatogenesis in mice.
Kroll MR; Viss ES; Lamb J; Horstman J; Powell A; Van Wyk A; Hinkkala K; Hoogland T; Schippers M; Shannon S; Carlton CG; Sharma M; Taylor A; Vanden Heuvel GB; Jelsma TN
Biol Reprod; 2011 Mar; 84(3):455-65. PubMed ID: 20980687
[TBL] [Abstract][Full Text] [Related]
19. Distinct clinical and biological implications of
Aly M; Ramdzan ZM; Nagata Y; Balasubramanian SK; Hosono N; Makishima H; Visconte V; Kuzmanovic T; Adema V; Nazha A; Przychodzen BP; Kerr CM; Sekeres MA; Abazeed ME; Nepveu A; Maciejewski JP
Blood Adv; 2019 Jul; 3(14):2164-2178. PubMed ID: 31320321
[TBL] [Abstract][Full Text] [Related]
20. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ
J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
